Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men and method to study the dyssynergia in male rodents

Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men and method to study the dyssynergia in male rodents

US Patent 6316431 · Granted Nov 13, 2001

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Medicine for Covid-19 and treatment2023
Medicine for Covid-19 and treatment2022
Medicine for Covid-19 and treatment2021
Method for the treatment or prevention of lower urinary tract symptoms2020
Method for the treatment or prevention of lower urinary tract symptoms2020
Prodrugs of 17β-HSD1-inhibitors2020
Methods for the treatment of erectile dysfunction using fispemifene2019
Prodrugs of 17.BETA.-HSD1-inhibitors2019
Therapeutically active estratrienthiazole derivatives as inhibitors of 17 B-hydr2019
Therapeutically active estratrienthiazole derivatives as inhibitors of 17 B-hydr2019
Method for the treatment or prevention of lower urinary tract symptoms2018
Method for the treatment or prevention of lower urinary tract symptoms2018